Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-18
DOI
10.3389/fgene.2018.00174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
- (2018) Bin Zhang et al. NATURE MEDICINE
- Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231
- (2017) Hamidreza Moazzeni et al. MOLECULAR AND CELLULAR PROBES
- Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
- (2017) Duncan Ayers et al. Genes
- miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
- (2016) Eric R. Lechman et al. CANCER CELL
- microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway
- (2016) Jie Gao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell
- (2016) Jingwen Liu et al. International Journal of Nanomedicine
- Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
- (2016) Mengjie Rui et al. International Journal of Nanomedicine
- Aberrant expression of miR-9 in benign and malignant breast tumors
- (2016) Aisan Hasanzadeh et al. MOLECULAR AND CELLULAR PROBES
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling
- (2015) Lingqiang Chen et al. ANNALS OF HEMATOLOGY
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- A global microRNA screen identifies regulators of the ErbB receptor signaling network
- (2015) Annabell Bischoff et al. Cell Communication and Signaling
- Targeting Of miR9/NOTCH1 Interaction Reduces Metastatic Behavior in Triple-negative Breast Cancer
- (2015) Samira Mohammadi-Yeganeh et al. Chemical Biology & Drug Design
- The Role of MicroRNAs in the Chemoresistance of Breast Cancer
- (2015) Jing Wang et al. DRUG DEVELOPMENT RESEARCH
- Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
- (2015) Melina Arnold et al. EUROPEAN JOURNAL OF CANCER
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer
- (2014) Jae Moon Gwak et al. BREAST CANCER RESEARCH AND TREATMENT
- CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
- (2014) Sadhna R. Vora et al. CANCER CELL
- miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
- (2014) Ufuk Berber et al. Journal of Breast Cancer
- Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
- (2014) Stefano Volinia et al. JNCI-Journal of the National Cancer Institute
- MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Xuyang Jiao et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis
- (2013) Jincai Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
- (2013) Andrea BISSO et al. CELL CYCLE
- The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
- (2013) Ying Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis
- (2013) Xiaojun Li et al. MEDICAL ONCOLOGY
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
- (2013) Jing Wang et al. NUCLEIC ACIDS RESEARCH
- Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer
- (2013) S. Volinia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA Expression Signatures in Solid Malignancies
- (2012) Marco Galasso et al. CANCER JOURNAL
- Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion
- (2012) Eric R. Lechman et al. Cell Stem Cell
- TGF-β upregulates miR-181a expression to promote breast cancer metastasis
- (2012) Molly A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
- (2012) Wei Tang et al. PLoS One
- Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
- (2012) S. Volinia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
- (2011) Ni Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
- (2011) Françoise Rothé et al. PLoS One
- MicroRNA-mediated drug resistance in breast cancer
- (2011) Kristy R. Kutanzi et al. Clinical Epigenetics
- A MicroRNA Targeting Dicer for Metastasis Control
- (2010) Graziano Martello et al. CELL
- Reprogramming of miRNA networks in cancer and leukemia
- (2010) S. Volinia et al. GENOME RESEARCH
- MicroRNAs as biomarkers
- (2010) NATURE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The cell growth suppressor, mir-126, targets IRS-1
- (2008) Jin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
- Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
- (2008) J. A. Foekens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic inactivation of microRNA genehsa-mir-9-1in human breast cancer
- (2007) U Lehmann et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now